On July 17, 2017, Borui Pharmaceutical was selected as the 11th batch of Suzhou's 2017 scientific and technological development plan (comprehensive improvement of technological innovation capabilities of science and technology enterprises) to accelerate the development of Borui Pharmaceutical 's innovation.

The city's science and technology development plan is to further implement the innovation-driven development strategy, and further support innovative leading enterprises and high-growth (gazelle plan) enterprises to improve their comprehensive innovation capabilities. The aim is to promote a group of high-tech, core competitiveness, and industry Emerging landmark technology companies have emerged.

Borui Pharmaceutical is a R & D-driven enterprise dedicated to the research and development of innovative drugs and high-end generic drugs. Relying on its deep R & D technical strength, Borui has created a R & D platform for generic and innovative drugs. From the development of drugs with high synthetic technology thresholds; to the development of semi-synthetic drugs with higher technical barriers as a new field of development; and to the construction of special preparation research and development platforms, these have made Borui Medicine one of the world's leading drug development companies.

Not only is it constantly expanding in the field of generic drugs, Borui Pharmaceuticals is also continuously working on innovative drugs. Currently, 1.1 innovative drugs under development are involved in the fields of anti-tumor, hepatic encephalopathy, anti-HBV, anti-fungus, and diabetes. Among them, new global anti-tumor drugs, GLP-1 oral long-acting diabetes drugs and drugs for treating hepatic encephalopathy have been developed. A major breakthrough has been achieved and clinical application will be made shortly.

So many and difficult R & D projects require a continuous and substantial investment. The Pharmaceutical Research Institute only has more than 120 high-performance liquid phases. At the same time, it has added high-end equipment such as nuclear magnetic resonance, liquid chromatography-mass spectrometry, and atomic absorption. Nano-vein iron and other new drug delivery technology platforms.

Being selected as the eleventh batch of science and technology development plan of Suzhou in 2017 is honor and encouragement. In the future , Borui Medicine will continue to strengthen the innovation system and mechanism, further enhance competitiveness, maintain high-speed growth, and achieve leapfrog development.